Royal Australian Navy - 👉 Bachelor of Electronic and Communications Engineering
Written For
Releaf, Business Of Cannabis, CPD, Cannabis Now Magazine, High Times, Cookies Seeds, Fast Buds, MSNL, Paradise Seeds, Premium Cultivars
Sam North is a content writer at Releaf, specialising in medical cannabis, digital health, and patient education within a UK regulatory framework.
After a decade immersed in the cultivation side of the cannabis industry, Sam moved into digital in 2020. He worked across the recreational space with seed companies, CBD brands, and cannabis publications, before transitioning into the medical cannabis sector in early 2023 and joining Releaf in April of that year.
Today, his work spans both content and SEO, with a focus on how the two support patient understanding and long-term organic growth. He writes and shapes educational content, research breakdowns, and patient-facing web copy, ensuring it is clear, clinically accurate, and aligned with UK compliance requirements.
At Releaf, Sam’s focus is on making medical cannabis more understandable and accessible to patients, while maintaining a high standard of accuracy, compliance, and trust.
Understanding CBD oil for fibromyalgia and what dose to take is one of the most common challenges for people with fibromyalgia. This guide explains how dosage works, why responses vary between individuals, and how prescribed CBD differs from over-the-counter options in terms of quality, consistency, and medical supervision.
Although the field of medical cannabis research may still be in its infancy, it is slowly (but surely) proving to be an effective and safe complementary treatment option for a wide range of medical conditions. One such condition is endometriosis, a distressing condition affecting the female reproductive system, characterized by the abnormal growth of endometrial tissue outside its usual location.
The cannabis sativa L. plant is one of the most versatile, and potentially therapeutically beneficial types of flora to ever grace this pale blue dot we call home. It is one of the fastest-growing plants, takes less water to cultivate than the vast majority of other crops, and has a wide range of applications due to not only the presence of cannabinoids, but also its true variability in terms of the production of textiles, paper products, and food items.
Despite advancements in understanding back pain, the lack of effective and lasting treatment options remains a significant challenge. Managing non-surgical back pain has been identified as a primary contributor to the current issues surrounding the overprescription of opioids. Additionally, post-operative pain management poses a complex challenge for patients undergoing spine surgery.
Eczema often appears in the first few months after birth and usually improves as children get older. Traditional treatments for mild cases focus on using cleansers and applying a fragrance-free moisturiser or ointment after bathing. Corticosteroids may also be used to treat inflammation and redness on the skin. Some parents prefer natural treatments over pharmaceutical options or as a complementary treatment, which is where hemp seed oil can be of benefit.
This updated 2025 guide explores the evidence around medical cannabis and cancer. From easing pain, nausea, appetite loss and anxiety to improving sleep, we review the latest research, risks, and patient pathways. Learn how UK patients can safely access prescriptions under medical supervision through Releaf’s platform.
The cannabis plant is a horticultural marvel. Its oil can be used as a salad dressing, its seeds are packed with protein and healthy fats, and its fibres make for a much more sustainable and durable alternative to cotton. What’s more, its stems, leaves, and buds are packed with compounds known to have a range of potential medicinal properties.
The UK has long been one of the world’s leading cannabis exporters, yet patients at home still face barriers to access. Using INCB data, this blog explores how much cannabis the UK exports, how it compares to Canada and other nations, the role of GW/Jazz Pharmaceuticals, and the future of domestically cultivated flower from Glass Pharms® and Dalgety.
Back pain continues to be a prevalent issue not only here in the UK, but globally. While there is a range of both 'over-the-counter' and prescribable pharmaceuticals available, many patients are seeking natural therapeutic options that don’t cause excessive side effects or risk of dependence and can be easily added to a holistic treatment plan.
Diagnoses of clinical depression are at an all-time high here in the UK. The COVID-19 pandemic brought with it a sharp hike in rates of both depression and anxiety – and while that period is, thankfully, slowly passing, life is still fraught with many challenges and uncertainties.
Are edibles legal in the UK? That depends on what they contain. CBD edibles are legal for ‘over-the-counter’ sale as long as the whole container has less than 1mg of THC and meet the FSA ‘Novel Food’ rules. Edibles with high levels of THC are only legal in the UK when prescribed by a specialist doctor, as THC is a controlled substance.
Since the 2020 pandemic, global rates of clinical depression diagnoses have risen dramatically, with more than an estimated 280 million people worldwide now suffering from depression. The same has been seen here in the UK, and in early 2021 more than 21% of adults living in the UK experienced some form of depression. That is more than double the pre-pandemic rate of 10%.
With rates of depression in the UK steadily rising, and only boosted by the recent pandemic, finding treatment solutions can be a daunting task. Now more than ever, it is important to understand all the potential treatment options available. One of those options may include taking medical cannabis as part of your therapeutic plan.
As interest in medical cannabis spreads around the UK, it’s understandable that accessing reliable information about its legal status has become a bit of a minefield. In this article, we will offer accurate and up-to-date information on UK cannabis classification, so that you can feel more confident in assessing your own position with regard to making a distinction between medical cannabis, and the cannabis that we associate with illegal substances.
Type 2 diabetes is the most commonly occurring form of the disease. Unlike type 1 diabetes, which results in sufferers being unable to produce insulin, type 2 diabetes causes the body to respond abnormally to insulin, ensuing in insulin resistance. People with type 2 diabetes will see the level of sugar (glucose) in their blood become too high, which, if left unmanaged, can result in serious, long-term health issues.
One of the most extreme anxiety disorders is post-traumatic stress disorder (PTSD). This condition is extremely complicated and can be debilitating for those affected. Fortunately, there is a substantial and ever-growing body of evidence to suggest that medical cannabis, and specifically CBD, may be an effective complementary therapy option that could help in alleviating the symptoms of PTSD.
Attention deficit hyperactivity disorder (ADHD) is a neurological condition that affects cognition, perception, attention, and impulsivity. It is one of the most commonly diagnosed neurological disorders. Although pharmaceutical medications are often prescribed to manage ADHD symptoms and behavioural therapy helps patients develop coping strategies, many are seeking alternative treatments.
CBD skincare is big news, with hundreds of products hitting the market in recent years. The skin is the body’s largest organ and is responsible for many crucial functions, including keeping germs out and protecting the body’s internal organs from infection. It prevents loss of moisture, protects organs from UV exposure and acts as a sensory organ detecting touch. It also regulates temperature and produces vitamin D, which is critical for building bone.
With the rise of depression diagnoses over the past 3 years globally, and also specifically here in the UK, it should come as anything but a surprise that researchers and healthcare professionals alike are keenly interested in finding new ways to help manage depression.
Obsessive-compulsive disorder (OCD) affects around 1.2% of the UK population, with approximately 750,000 of us affected by the illness at any one time. This mental health condition can be challenging to live with, resulting in extreme anxiety and dread, intrusive thoughts and compulsive behaviours that feel necessary to keep these thoughts and anxieties at bay. The condition can be incredibly disruptive to one’s professional, personal and social life, with symptoms proving difficult and sometimes debilitating.
Sleep is an absolutely vital component of our mental and physical health. But the unfortunate truth is that many of us are simply not getting enough of it. While many of us experience the odd sleepless night due to the daily stresses of modern-day life, one too many cappuccinos at work, or an oppressively hot and muggy summer evening, an ongoing loss of sleep could be categorised as insomnia.
Many of us know how it feels to endure a sleepless night. Heat and humidity, noisy neighbours, or the worries and stresses of daily life can all prevent us from finding the restful state needed for good quality sleep. Most of the time, this transient insomnia comes and goes as external conditions become more favourable. Over time, however, a prolonged lack of sleep may lead to chronic insomnia.
While the vast majority of the people living in developed countries have a healthy relationship with food, the scourge of eating disorders is on the rise, with millions worldwide facing anorexia, bulimia, and other disordered eating behaviours. In the UK alone, current estimates suggest that around 1.25 million people are affected by some type of eating disorder.
Eating disorders (ED) are among the most common mental illnesses, and some of the most debilitating, with an estimated 1.25 to 3.4 million people affected in the United Kingdom alone. Eating disorders most often develop during adolescence, although there are cases where people as old as seventy and as young as six years old have been diagnosed.